Can concurrent mycotoxin and toxic-metal exposure increase biological stress?

Concurrent exposure to foodborne mycotoxins and toxic metals is biologically credible as a multi-hit stressor, but the strongest evidence remains experimental and mixture-specific rather than human clinical evidence.

Experimental and mechanistic evidence

• In Caenorhabditis elegans, 24-hour fumonisin B₁–cadmium co-exposure produced dose-dependent worsening of oxidative injury and mitochondrial dysfunction, including altered mitochondrial membrane-protein expression and disrupted fission/fusion dynamics. This directly supports convergence on mitochondrial injury and, in selected models, greater stress than either toxicant alone.
• The same pairing induced ferroptosis-associated changes, including increased unstable ferrous iron and altered ferroptosis-related gene expression. DON–lead co-exposure in human kidney cells likewise altered iron and ferroptosis markers, with low-dose synergy but high-dose antagonism—illustrating that interaction direction depends on concentration and model.
• Oxidative-stress convergence is mechanistically plausible: OTA can increase ROS and malondialdehyde while lowering glutathione in HepG2 cells; aflatoxin B₁ has been associated with increased MDA and 8-OHdG. However, direct evidence that a defined mycotoxin–metal mixture raises these redox biomarkers beyond both individual exposures remains limited.

Barrier and inflammatory implications

• Cadmium plus OTA aggravated intestinal epithelial-barrier dysfunction in Caco-2 and pig intestinal epithelial models. Because OTA can engage TLR4/MyD88-associated IL-1β/IL-6 responses and cadmium can affect NF-κB/MAPK and cytokines, inflammatory convergence is biologically coherent, but not directly demonstrated for the mixture.

Clinical interpretation

• Effects cannot be assumed to be universally additive or synergistic: cadmium–aflatoxin B₁ toxicity in mice was additive, while other combinations show antagonism under some conditions. Human co-exposure studies have not established oxidative, mitochondrial, inflammatory, or clinical interaction effects.

Bottom line

• Particular mycotoxin–metal combinations can amplify mitochondrial, redox, ferroptotic, and epithelial-barrier injury in experimental systems; whether this translates into increased biological stress in people—especially at real-world exposure levels—remains unproven.